Menu

Theranos CEO Presents New Device

The troubled firm’s medical conference appearance didn’t deliver the evidence many hoped for.

Aug 2, 2016
Kerry Grens

FLICKR, STEVE JURVETSONBlood-testing company Theranos, which has been in hot water with federal regulators after selling tests to consumers that were not accurate, is trying to get back in the game. While CEO Elizabeth Holmes has been banned from operating a lab for two years, she presented her firm’s latest technology yesterday (August 1) at the American Association for Clinical Chemistry (AACC) conference—to what appears to have been a rather unimpressed crowd.

“Regarding Theranos’ broad claims of being able to run 70-plus tests on a single drop of blood, AACC [panel/session] moderator Stephen Master told Holmes, ‘The evidence you presented fell far short of that,’” Business Insider reported. “The comment was met with applause from the audience.”

Theranos has been criticized for its secrecy, not publishing data in peer-reviewed journals or presenting at scientific conferences. Although Holmes’s presence yesterday seemed like a step in direction of transparency, “the technology she described, however, roughly echoed the unproven breakthroughs previously claimed by the company,” MIT Technology Review reported.

Holmes debuted Theranos’s so-called miniLab, which she said will someday be able to run 160 different assays, from lipid panels to Zika tests, according to STAT News. If the machine can accomplish what Holmes claims, it would be an impressive device. “I’ve never seen anybody put this much stuff in a box,” Danyel Tacker, an associate professor of pathology at West Virginia University, told STAT.

While Holmes offered up data from within Theranos, she did not present any externally validated results to the packed room. “In my mind, Theranos shouldn’t get to trade on the publicity they’ve gotten for the trouble they’ve had,” Master told Wired, “and then get to say to everybody, ‘Oh, and you guys have to pretend we are starting from scratch.’”

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.